TeneoBio, Inc.

1490 O’Brien Drive
Suite D
Menlo Park
United States

Tel: 650-899-8200

Email: busdev@teneobio.com

Show jobs for this employer

About TeneoBio, Inc.

TeneoBio, Inc. is a biotechnology company that is developing a new class of biologics, Human Heavy Chain Antibodies (UniAbs™), as therapeutics against cancer, autoimmunity, and infectious diseases. TeneoBio has several products in pre-clinical development for the treatment of multiple myeloma, prostate cancer, immune disorders and AIDS.


CEO: Roland Buelow

CFO: Stephen Dance

CMO: Ben Buelow

CSO: Wim van Schooten

CBO: Omid Vafa

9 articles with TeneoBio, Inc.